Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

Abstract

Stimulatory autoantibodies against PDGFR appear to be a specific hallmark of scleroderma. Their biologic activity on fibroblasts strongly suggests that they have a causal role in the pathogenesis of the disease.